Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests

Alvise Berti, E. Della-Torre, M. R. Yacoub, E. Tombetti, V. Canti, M. G. Sabbadini, G. Colombo

Research output: Contribution to journalArticle

Abstract

Background. The term “breakthrough reactions” designates repeated hypersensitivity reactions to iodinated contrast media (ICM) despite premedication with glucocorticoids and antihistamines. We aimed to retrospectively evaluate the rate of positive skin test (STs) in our cohort of patients with previous breakthrough reactions to different ICMs. Methods. A series of 35 patients, who experienced at least one breakthrough reaction to ICM and who underwent STs within 6 months from the reaction were studied, and results were compared to a control group of patients with a first hypersensitivity reaction occurred without premedication. Skin prick tests (SPT), intradermal tests (IDT) and patch tests (PT) at different dilutions, with a set of three to four ICM were performed. Results. Of the 35 patients with prior breakthrough reactions, 57% had an immediate reaction (IR) and 43% had a non-immediate reaction (NIR). Patients who experienced the first hypersensitivity IR or NIR, later had one or more breakthrough IR or NIR, respectively. Overall, 29% (10/35) of patients with prior breakthrough reactions resulted positive to STs compared to 57% (16/28) of the control group (p < 0.05). No significant difference in allergy history, age, sex, other clinical / demographic features nor chronic use of ACE-inhibitor, beta-blockers or NSAIDs was observed. Conclusions. This preliminary finding suggests that patients with prior breakthrough reactions have significantly lower immunologically proven ICM reactions (positive STs) if compared to non-breakthrough patients. According to that, a considerable number of breakthrough reactions seems to be non-allergic hypersensitivity reactions or reactions which could be mostly prevented by a proper, well-timed skin testing. Larger prospective studies are needed to confirm these results, with a more careful analysis of patients’ risk factors, a laboratory assessment that includes an in vitro allergy diagnostics, and hopefully a drug provocation test for selected cases.

Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalEuropean Annals of Allergy and Clinical Immunology
Volume48
Issue number4
Publication statusPublished - 2016

Keywords

  • Breakthrough reactions
  • Hypersensitivity
  • Intradermal tests
  • Iodinated contrast media
  • Skin tests

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests'. Together they form a unique fingerprint.

  • Cite this

    Berti, A., Della-Torre, E., Yacoub, M. R., Tombetti, E., Canti, V., Sabbadini, M. G., & Colombo, G. (2016). Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests. European Annals of Allergy and Clinical Immunology, 48(4), 137-144.